ATE342048T1 - Neue aerosolformulierungen ein polares fluoriniertes molekül enthaltend - Google Patents

Neue aerosolformulierungen ein polares fluoriniertes molekül enthaltend

Info

Publication number: ATE342048T1
Authority: AT; Austria
Prior art keywords: formulations containing; aerosol formulations; polar fluorinated; new aerosol; fluorinated molecule
Prior art date: 2000-07-11

Application number

AT01952071T

Other languages

English (en)

Inventor

Philippe Rogueda

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-11

Filing date

2001-07-10

Publication date

2006-11-15

2001-07-10 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2006-11-15 Application granted granted Critical

2006-11-15 Publication of ATE342048T1 publication Critical patent/ATE342048T1/de

Links

239000000203 mixture Substances 0.000 title abstract 4
239000000443 aerosol Substances 0.000 title 1
238000009472 formulation Methods 0.000 abstract 2
239000003380 propellant Substances 0.000 abstract 2
YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 abstract 1
LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical group FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
239000008249 pharmaceutical aerosol Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Organic Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT01952071T 2000-07-11 2001-07-10 Neue aerosolformulierungen ein polares fluoriniertes molekül enthaltend ATE342048T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0016876.5A GB0016876D0 (en)	2000-07-11	2000-07-11	Novel formulation

Publications (1)

Publication Number	Publication Date
ATE342048T1 true ATE342048T1 (de)	2006-11-15

Family

ID=9895336

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01952071T ATE342048T1 (de)	2000-07-11	2001-07-10	Neue aerosolformulierungen ein polares fluoriniertes molekül enthaltend

Country Status (21)

Country	Link
US (1)	US20030194378A1 (de)
EP (1)	EP1303258B1 (de)
JP (1)	JP2004502719A (de)
KR (1)	KR20030025265A (de)
CN (1)	CN1455663A (de)
AT (1)	ATE342048T1 (de)
AU (2)	AU2001272866B2 (de)
BR (1)	BR0112322A (de)
CA (1)	CA2415092A1 (de)
CY (1)	CY1105913T1 (de)
DE (1)	DE60123793T2 (de)
DK (1)	DK1303258T3 (de)
ES (1)	ES2273864T3 (de)
GB (1)	GB0016876D0 (de)
IL (2)	IL153726A0 (de)
MX (1)	MXPA03000276A (de)
NO (1)	NO20030133L (de)
NZ (1)	NZ523379A (de)
PT (1)	PT1303258E (de)
WO (1)	WO2002003958A1 (de)
ZA (1)	ZA200300075B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0759042A (ja) *	1993-08-13	1995-03-03	Toshiba Corp	画像保管装置
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
EP1453524A2 (de) *	2001-12-04	2004-09-08	Minnesota High-Tech Resources, LLC	Atembare gasgemische zur regelung der körpertemperatur
DE60231428D1 (de)	2001-12-21	2009-04-16	3M Innovative Properties Co	Medizinische aerosolzusammensetzungen mit einem funktionalisierten polyethylenglykol-hilfsstoff
KR20040081753A (ko) *	2002-02-01	2004-09-22	아스트라제네카 아베	흡입용 조성물
SE0200312D0 (sv)	2002-02-01	2002-02-01	Astrazeneca Ab	Novel composition
SE0203376D0 (sv) *	2002-11-15	2002-11-15	Astrazeneca Ab	New process
FR2851166A1 (fr) *	2003-02-13	2004-08-20	D Lab	Utilisation d'un liquide volatil a pression atmospherique et a temperature ambiante pour la fabrication de compositions pharmaceutiques et/ou biologiques
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
US20070020299A1 (en)	2003-12-31	2007-01-25	Pipkin James D	Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20060188729A1 (en) *	2005-02-22	2006-08-24	Kai-Volker Schubert	Washable leather with repellency
DE102007025898A1 (de) *	2007-06-01	2008-12-04	Matthias W. Dr. Amrein	Behandlung von Surfactanten
WO2008152398A2 (en) *	2007-06-14	2008-12-18	Cipla Limited	Formulations for inhalation
ES2493641T3 (es) *	2007-06-28	2014-09-12	Cydex Pharmaceuticals, Inc.	Administración nasal de soluciones acuosas de corticosteroides
US12370352B2 (en)	2007-06-28	2025-07-29	Cydex Pharmaceuticals, Inc.	Nasal and ophthalmic delivery of aqueous corticosteroid solutions
US20090012250A1 (en) *	2007-07-03	2009-01-08	Yu-Chin Lai	Novel polymerizable surface active monomers with both fluorine-containing groups and hydrophilic groups
KR100910848B1 (ko) *	2007-09-13	2009-08-06	재단법인서울대학교산학협력재단	알러지성 비염 치료약물을 유효성분으로 함유하는 비강분무용 마이크로스피어 및 이의 제조방법
US8586007B2 (en) *	2007-10-19	2013-11-19	Wayne State University	Co-polymer stabilizers for hydrofluoroalkane dispersions
EP2294044B1 (de) *	2008-04-28	2016-07-13	AL.CHI.MI.A. S.r.l.	Fluoralkyloxyalkane, verfahren zur herstellung und anwendungen davon
US20120219596A1 (en) *	2009-07-30	2012-08-30	Wendelin Stark	Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event
JP5639069B2 (ja) *	2009-10-09	2014-12-10	株式会社クレハ	新規なフッ化ビニリデン共重合体及びその製造方法
EP2407150A1 (de) *	2010-07-16	2012-01-18	Justus-Liebig-Universität Gießen	Nano- und Mikropolymerpartikel zur Aufrechterhaltung einer niedrigen Oberflächenspannung in der Lunge und zum Schutz des pulmonalen Surfactants
EP2874737B1 (de) *	2012-07-18	2018-11-07	Merck Patent GmbH	Fluortenside
KR101516057B1 (ko) *	2012-12-07	2015-04-30	가톨릭대학교 산학협력단	폐질환 치료용 흡입 제형 및 이의 제조방법
CN109464429B (zh) *	2018-12-13	2021-04-27	上海方予健康医药科技有限公司	一种吸入压力定量气雾剂药物组合物及其制备方法
US20200306171A1 (en) *	2019-04-01	2020-10-01	Honeywell International Inc.	Personal care aerosol compositions, methods and devices

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3557294A (en) *	1967-10-12	1971-01-19	Allied Chem	Fluorinated ethers as inhalation convulsants
IE67185B1 (en) *	1990-02-02	1996-03-06	Fisons Plc	Propellant compositions
US5605882A (en) *	1992-05-28	1997-02-25	E. I. Du Pont De Nemours And Company	Azeotrope(like) compositions of pentafluorodimethyl ether and difluoromethane
US5376359A (en) *	1992-07-07	1994-12-27	Glaxo, Inc.	Method of stabilizing aerosol formulations
GB9419536D0 (en) *	1994-09-28	1994-11-16	Glaxo Inc	Medicaments
CA2218179A1 (en) *	1995-04-14	1996-10-17	Glaxo Wellcome Inc.	Metered dose inhaler for beclomethasone dipropionate
US5874469A (en) *	1996-01-05	1999-02-23	Alcon Laboratories, Inc.	Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
US5730894A (en) *	1996-04-16	1998-03-24	E. I. Du Pont De Nemours And Company	1,1,2,2,3,3,4,4-octafluorobutane azeotropic (like) compositions
US6458373B1 (en) *	1997-01-07	2002-10-01	Sonus Pharmaceuticals, Inc.	Emulsion vehicle for poorly soluble drugs
DK1014943T3 (da) *	1997-02-05	2002-10-14	Jago Res Ag	Medicinske aerosolformuleringer
US6086376A (en) *	1998-01-30	2000-07-11	Rtp Pharma Inc.	Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

2000
- 2000-07-11 GB GBGB0016876.5A patent/GB0016876D0/en not_active Ceased
2001
- 2001-07-10 US US10/332,568 patent/US20030194378A1/en not_active Abandoned
- 2001-07-10 AT AT01952071T patent/ATE342048T1/de active
- 2001-07-10 BR BR0112322-0A patent/BR0112322A/pt not_active Application Discontinuation
- 2001-07-10 WO PCT/SE2001/001606 patent/WO2002003958A1/en not_active Ceased
- 2001-07-10 JP JP2002508413A patent/JP2004502719A/ja active Pending
- 2001-07-10 AU AU2001272866A patent/AU2001272866B2/en not_active Ceased
- 2001-07-10 NZ NZ523379A patent/NZ523379A/en not_active IP Right Cessation
- 2001-07-10 MX MXPA03000276A patent/MXPA03000276A/es active IP Right Grant
- 2001-07-10 AU AU7286601A patent/AU7286601A/xx active Pending
- 2001-07-10 CN CN01815467A patent/CN1455663A/zh active Pending
- 2001-07-10 CA CA002415092A patent/CA2415092A1/en not_active Abandoned
- 2001-07-10 EP EP01952071A patent/EP1303258B1/de not_active Expired - Lifetime
- 2001-07-10 DE DE60123793T patent/DE60123793T2/de not_active Expired - Lifetime
- 2001-07-10 DK DK01952071T patent/DK1303258T3/da active
- 2001-07-10 ES ES01952071T patent/ES2273864T3/es not_active Expired - Lifetime
- 2001-07-10 IL IL15372601A patent/IL153726A0/xx unknown
- 2001-07-10 KR KR10-2003-7000349A patent/KR20030025265A/ko not_active Ceased
- 2001-07-10 PT PT01952071T patent/PT1303258E/pt unknown
2002
- 2002-12-29 IL IL153726A patent/IL153726A/en not_active IP Right Cessation
2003
- 2003-01-03 ZA ZA200300075A patent/ZA200300075B/en unknown
- 2003-01-10 NO NO20030133A patent/NO20030133L/no unknown
2007
- 2007-01-09 CY CY20071100028T patent/CY1105913T1/el unknown

Also Published As

Publication number	Publication date
MXPA03000276A (es)	2003-06-06
EP1303258A1 (de)	2003-04-23
NO20030133L (no)	2003-02-24
IL153726A0 (en)	2003-07-06
DE60123793D1 (de)	2006-11-23
EP1303258B1 (de)	2006-10-11
ZA200300075B (en)	2004-04-05
KR20030025265A (ko)	2003-03-28
WO2002003958A1 (en)	2002-01-17
AU2001272866B2 (en)	2005-08-11
BR0112322A (pt)	2003-07-08
JP2004502719A (ja)	2004-01-29
AU7286601A (en)	2002-01-21
CY1105913T1 (el)	2011-04-06
NZ523379A (en)	2004-06-25
DE60123793T2 (de)	2007-09-06
CA2415092A1 (en)	2002-01-17
US20030194378A1 (en)	2003-10-16
ES2273864T3 (es)	2007-05-16
IL153726A (en)	2008-07-08
NO20030133D0 (no)	2003-01-10
CN1455663A (zh)	2003-11-12
PT1303258E (pt)	2007-01-31
GB0016876D0 (en)	2000-08-30
DK1303258T3 (da)	2007-01-22

Legal Events

Date

Code

Title

Description

2007-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1303258

Country of ref document: EP

Publication	Publication Date	Title
DE60123793D1 (de)	2006-11-23	Neue aerosolformulierungen ein polares fluoriniertes molekül enthaltend
EA199900991A1 (ru)	2000-08-28	Медицинские аэрозольные препараты
ATE342053T1 (de)	2006-11-15	Formulierungen zur inhalation
DE60001492D1 (de)	2003-04-03	Pharmazeutische aerosolformulierung
NZ509328A (en)	2002-11-26	Medicinal aerosol formulations
DE69208660D1 (de)	1996-04-04	Fluorchlorkohlenwasserstoffreie aerosolformulierungen
ATE216575T1 (de)	2002-05-15	Treibgasmischung für eine aerosolzubereitung
DE69932835D1 (de)	2006-09-28	Medizinische aerosolzubereitung
ATE215359T2 (de)	2002-04-15	Aerosolformulierungen
PT1014943E (pt)	2002-11-29	Formulacoes medicinais de aerossois
BR9712125A (pt)	1999-08-31	Formulação farmaucêutica em aerosol, uso de uma mistura, produto farmacêutico, e, processo de administração de budesonida a um paciente
ATE343374T1 (de)	2006-11-15	Fluticasonpropionat arzneizubereitung
ECSP088732A (es)	2008-10-31	Aerosoles dosificadores para la administración de preparaciones farmacéuticas
MA26392A1 (fr)	2004-12-01	Respirateur aerosol
BR9916830A (pt)	2001-11-06	Formulações aerossóis farmacêuticas contendo fluoroalcanos e budesonide
MX9301410A (es)	1993-09-01	Composiciones farmaceuticas en aerosol conteniendo la sustancia activa flezelastina y estructuras afines.
ATE286716T1 (de)	2005-01-15	Pharmazeutische formulierungen enthaltend salmeterol
TH29519B (th)	1998-08-14	สูตรผสมทางเภสัชศาสตร์ที่เสถียรชนิดใหม่สำหรับการผลิตละอองลอยที่ไม่มีแก๊สผลักดัน